Showing posts with label Comments from Walgreens to FDA Guidance Re: 503A. Show all posts
Showing posts with label Comments from Walgreens to FDA Guidance Re: 503A. Show all posts

Saturday, February 8, 2014

Comments from Walgreens to FDA Guidance Re: 503A

Comment from Walgreens
null
  • Subject: Docket No. FDA–2013-D–1444: Pharmacy Compounding of Human Drug Products Under Section 503A of the FDCA Walgreen Co. (“Walgreens”) is pleased to submit comments to the...

  • Public Submission
  • Posted:
    02/06/2014
  • ID:
    FDA-2013-D-1444-0025
- No comments:
Labels:
Subscribe to: Posts (Atom)